MMP9 and acute myocardial infarction: According to the mouse experiments of Masanobu (39), it was predicted that LCZ696 could inhibit pro-inflammatory cytokines, matrix metalloproteinase-9 activity, and aldosterone production, and clinically help to improve the survival rate after acute myocardial infarction.